Prevalence of ST131 and ST1193 Among Bloodstream Isolates of Escherichia coli not Susceptible to Ciprofloxacin in a Tertiary Care University Hospital in Korea, 2013 - 2014

Clin Lab. 2017 Sep 1;63(9):1541-1543. doi: 10.7754/Clin.Lab.2017.170319.

Abstract

We investigated the ST distribution of bloodstream isolates of E. coli that were not susceptible to ciprofloxacin (CIP-NS isolates), collected from 2013 to 2014 in a tertiary care hospital. Fifty-nine CIP-NS isolates were collected. ST131 was the most frequent ST (37.3%) isolate, followed by ST1193 (23.7%). ST131 and ST1193 showed significant differences in ESBL production and lactose fermentation. Further study should be continued on the monitoring of resistant strains.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Ciprofloxacin / pharmacology*
  • Drug Resistance, Bacterial*
  • Escherichia coli / classification
  • Escherichia coli / isolation & purification*
  • Escherichia coli Infections*
  • Hospitals, University
  • Humans
  • Prevalence
  • Republic of Korea
  • Tertiary Healthcare
  • beta-Lactamases

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • beta-Lactamases